Find your next paid study

Guardant Health, Inc.NCT06880055

~$10 – $1,050

CholangiocarcinomaColorectal CancerNon-Small Cell Lung Cancer+1 more

Phase I, Open-Label Study of Autologous Mutant KRAS and ILT4-Redirected T-cell Receptor Cells (TCR1188-ABC)

This is a Phase I, open-label dose finding study to assess the safety, manufacturing feasibility, and preliminary efficacy of TCR1188-ABC cells in patients wit…

University of PennsylvaniaNCT07594067

An Analysis of the Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery at the University of Arkansas for Medical Sciences

This is an observational study to look at the impact of the Enhanced Recovery After Surgery system for colorectal surgery (Group 1) in shortening hospital leng…

ColoRectal Cancer and Inflammatory Bowel Disease

University of ArkansasNCT02997293

~$10 – $750

Observational

Safety and Effectiveness Evaluations of the COLO-BT™ (Colorectal Balloon Tube) as an Alternative Treatment to the Temporary Ileostomy Following Proctectomy

The purpose of this study is to evaluate the Colorectal Balloon Tube (hereinafter referred to as COLO-BT™) device, a single use, temporary intraluminal bypass …

Colorectal SurgeryColorectal CancerRectal/Anal+2 more

JSR Medical Co., Ltd.NCT05826743

Colorectal CancerPancreatic CancerMelanoma+13 more

A First-in-human, Phase I, Multi-center, Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Evidence of Antitumor Activity of IDOV-Immune in Adult Participants With Advanced Solid Tumors

This is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid …

ViroMissile, Inc.NCT06910657

Phase 2

ULtra sensiTive ctDNA-Informed Management eArly-stage recTal cancEr (ULTIMATE)

This is a phase 2 pragmatic study to examine the utility of ctDNA-informed treatment management for participants with early-stage rectal cancer using the Signa…

Rectal AdenocarcinomaRectal CancerEarly-stage Rectal Cancer+1 more

University of California, DavisNCT07209215

Colorectal Cancer (Diagnosis)Adenoma

A Phase I Trial of S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas

This study will enroll a total of 18 patients who have undergone curative surgery for stage I or II colorectal cancer and are planned for post-surgical surveil…

Colorectal CancerEndometrial CancerHereditary Cancer Syndromes

~$10 – $7,500

Jun Gong, MDNCT07582003

Discovering New Targets for Hereditary and Sporadic Colorectal and Endometrial Cancer Risk Reduction

The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or…

Weill Medical College of Cornell UniversityNCT06096688

~$10 – $750

Advanced Solid TumorsMetastatic Solid TumorsNon-small Cell Lung Cancer (NSCLC)+3 more

A Phase 1/2 Open-Label, Multicenter Study of RAS(ON) Inhibitors in Combination With Ivonescimab With or Without Other Anti-Cancer Agents in Patients With Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of RAS(ON) inhibitors in combinati…

Revolution Medicines, Inc.NCT07397338

Observational

Trial of Meaning Centered Psychotherapy for Mexican Patients With Advanced Cancer

The purpose of this study is to find out if Meaning-Centered Psychotherapy for Latinos (MCP-L) helps reduce anxiety and depression and improves quality of life…

Breast CancerProstate CancerColorectal Cancer+9 more

Memorial Sloan Kettering Cancer CenterNCT07225309

Colorectal CancerGastro Esophageal Junctional CancerGastric Cancer (GC)+5 more

A Phase 1 Dose Escalation Trial to Determine the Safety, Tolerance, Maximum Tolerated Dose, and Preliminary Antineoplastic Activity of the IKS04 Regimen Targeting CA242

This study will evaluate the safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of the IKS04 Regimen and identify…

Iksuda Therapeutics Ltd.NCT07738939

Colorectal CancerPancreatic Cancer

Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Adenocarcinoma

Phase 1b study evaluating the efficacy and immune response to a synthetic long peptide mutant KRAS vaccine (SPL mKRASvax) combined with Balstilimab and Botensi…